title: Pharmacogenetic guidance for antiplatelet treatment.
authors.forename: Young-Hoon
authors.initials: YH
authors.lastname: Jeong
authors.forename: Kevin P
authors.initials: KP
authors.lastname: Bliden
authors.forename: Yongwhi
authors.initials: Y
authors.lastname: Park
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
authors.forename: Paul A
authors.initials: PA
authors.lastname: Gurbel
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D005260:Female; D006580:Genetic Carrier Screening; D005820:Genetic Testing; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019095:Point-of-Care Systems; D057285:Precision Medicine; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D001189:Aryl Hydrocarbon Hydroxylases